Fairley (1) proved by the results of glucose tolerance tests, and Barker and Rhoads (2) by fat tolerance tests, that the absorption of sugar and fat by patients with sprue is improved after treatment with liver extract. Moreover, Groen (3) observed that the diminished rate of absorption of glucose by the intestinal tract of 3 patients with pernicious anemia became normal after similar therapy.
Fairley (1) proved by the results of glucose tolerance tests, and Barker and Rhoads (2) by fat tolerance tests, that the absorption of sugar and fat by patients with sprue is improved after treatment with liver extract. Moreover, Groen (3) observed that the diminished rate of absorption of glucose by the intestinal tract of 3 patients with pernicious anemia became normal after similar therapy.
From these observations it was concluded that in both sprue and pernicious anemia a dysfunction of the intestinal tract is present which may be corrected by some constituent of liver extract. These conclusions were not entirely warranted, however, since no proof was advanced that simple diarrhea, or ischemia of the intestine, unrelated to liver extract deficiency, would not result in a similar interference with absorption. Moreover, the evidence concerning the malabsorption of glucose and of fat is repeatedly advanced as proof that the effective principle of liver extract is also poorly absorbed. No adequate experimental data bearing on this point are at hand, however, since the studies of Dakin, Ungley, and West (4) and of Subbarow, Jacobson, and Hartfall (5) indicate that the active substance is a breakdown product of protein, probably a peptide. Accordingly, studies have been made of the absorption of an amino acid, glycine, by patients with sprue and pernicious anemia, as well as with other disorders. The results are presented in this communication.
The glycine tolerance test was employed to obtain information concerning both the rate of absorption of the amino acid and the speed with which it is metabolized. Studies were made before and after the intramuscular administration of liver extract to 2 patients with sprue and to 5 patients with pernicious anemia. Twelve other patients-3 with pernicious anemia in induced remissions, 4 with ulcerative colitis, 3 with refractory anemia, and 2 with hepatic cirrhosis-were subjected to single tests and served as control cases.
The tests were made by the measurement of the levels of the plasma amino nitrogen and the plasma and urinary urea nitrogen before and after the ingestion of glycine. The levels of the plasma amino nitrogen are considered to indicate the rates of absorption and deaminization of the amino acid, whereas the levels of the plasma and urinary urea nitrogen indicate the rates of urea formation and excretion. Kirk (6) has reviewed the evidence that most, if not all, of the urea in the blood is formed in the liver, and that absorbed amino acids are deaminized by that organ as well as by the kidneys. He also showed by the results of glycine tolerance tests that patients with acute uremia are not able to deaminize glycine as rapidly as normal individuals or as patients with chronic uremia.
Heath and Fullerton (7) studied the levels of the plasma amino nitrogen after the oral as well as the intravenous administration of glycine. They concluded that "the amino acid nitrogen content of the blood following the ingestion of 25 grams of glycine gives no useful information regarding the rate of absorption from the gastro-intestinal tract." It should be noted that the studies upon which these conclusions were based did not include determinations of the plasma urea nitrogen levels. Hence no information concerning the rate of deaminization was available. If this were low, a plasma amino nitrogen curve within normal limits might follow the administration of glycine, even though absorption was impaired. Furthermore, no information is presented regarding the blood levels of the 2 tested patients with pernicious anemia in relapse.
METHODS
The glycine tolerance test (8) was made by the oral administration of 25 grams of glycine dissolved in 500 cc. of water to the fasting patient at 9 A.M. Blood samples were withdrawn before the amino acid ingestion, and at 10 A.M., 11 A.M., 12 noon, 1 P.M., and 3 P.M. Urine was collected from 9 A.M. to 12 noon, and from 12 noon to 3 P.M.
Plasma amino nitrogen and plasma and urinary urea nitrogen levels were determined by the methods of Van Slyke (9) . The normal plasma amino nitrogen and plasma urea nitrogen curves after the ingestion of glycine, as established by Kirk and Witts (6, 8) , are represented in each figure (Figures 1 to 7) . Kirk also has shown that normal fasting individuals after the ingestion of 25 grams of glycine (or 4670 mgm. of amino nitrogen) excrete in the urine approximately 2000 mgm. of urea nitrogen during the first 3 hours, and approximately 1000 mgm. during the second 3 hours. The total amount of urea formed during the test is ascertained from the total output of urea in the urine plus the increase of the urea content of the body.
Liver function tests a. Urobilinogen excretion in the urine. The Watson-Terwen (10) method was used. The excretion of urobilinogen in the urine of 25 normal individuals was found to be less than 2 mgm. a day.
b. The bilirubin excretion test described by Harrop and Barron (11) was made by injecting intravenously 1 mgm. of crystalline bilirubin per kilo of body weight. A retention after 4 hours of more than 5 per cent of the injected pigment was regarded as evidence of hepatic dysfunction.
c. The sodium benzoate conversion test described by Quick (12) was made by administering orally 5.9 grams of sodium benzoate. An excretion in the urine in 4 hours of less than 3 grams of hippuric acid in the presence of normal renal function was regarded as evidence of hepatic dysfunction.
Renal function tests The urea clearance test was used (13 November 7, 1938 , complaining of weakness, loss of weight, diarrhea, and pallor (see Figure 1) . The patient had been a missionary for 12 years in China and the Philippine Islands. She contracted diarrhea and returned to this country with a diagnosis of sprue 3 years before admission. The symptoms were controlled by the administration of liver extract but 6 months previous to admission the therapy was discontinued, and she was admitted in a severe relapse. She was a pale, sallow woman who appeared to be chronically ill. The tongue was reddened and showed marked papillary atrophy. The abdomen was distended with gas. Free hydrochloric acid was present in the fasting gastric juice after injection of histamine. The Figure 2) . The history was irrelevant until 6 months previous to admission when he noticed gradually increasing weakness associated with cramps in the calves of the legs and in the feet. Two months later numbness appeared in the feet, and gradually ascended to Figure 3 ). One year previous to admission the patient had noted anorexia and difficulty in walking. She was treated with liver extract and a remission occurred, but therapy was discontinued and she was admitted in a relapse. Figure 3 ). Three years before the patient had noted gradually increasing weakness and pallor. Later blurred vision and numbness in the finger tips developed and liver extract was administered. Improvement followed, but therapy was discontinued and a relapse ensued. Lextron had been taken before admission without clinical effect. She was well developed but slender. In the retinal vessels numerous sclerotic areas were visible. The oral mucous membranes were normal and the vibratory sense was poor. The red blood cell Figure 1) The glycine tolerance test was made on both patients (Cases 1 and 2) when the hemoglobin levels (28 per cent and 38 per cent) and the red blood cell levels (850,000 and 1,350,000) were low. The test was repeated after 5 and 2 months, respectively, of adequate liver extract therapy when the hemoglobin levels (71 per cent and 87 per cent) and the red blood cell levels (3,530,000 and 3,580,000) were nearer the normal. The patients, before treatment, were having 2 or 3 watery, offensive stools a day, but after treatment their bowel function was normal.
Before therapy. In both patients the plasma amino nitrogen curves were flat and low. The plasma urea nitrogen curves were also somewhat below those of normal individuals and during the 6 hours following the ingestion of glycine 2180 mgm. and 2870 mgm. respectively, of urea were formed. The results of the renal function tests were normal (70 per cent and 85 per cent), but those of the liver function tests were not. The first patient (Case 1) excreted daily in the urine an average of 2.3 to 5.0 mgm. of urobilinogen during several 3-day test periods, retained 20 per cent of the injected bilirubin in the plasma after 4 hours, and excreted only 1.3 grams of hippuric acid in the urine in a 4-hour period following the ingestion of 5.9 grams of sodium benzoate. The second patient (Case 2) excreted an average of 4.9 mgm. of urobilinogen, retained 68 per cent of the bilirubin and excreted 1.2 grams of hippuric acid.
After therapy. The plasma amino nitrogen curves were somewhat flattened but were within the normal range. The plasma urea nitrogen curves were essentially normal and 3492 mgm. and 3161 mgm. of urea were formed. The results of the renal function tests remained normal and the results of the liver function tests returned to normal. The first patient (Case 1) excreted 0.8 mgm. of urobilinogen, retained 5 per cent of bilirubin and excreted 2.8 grams of hippuric acid in the urine. The second (Case 2) excreted 1.0 mgm., retained only 2 per cent of the bilirubin and excreted 3.1 grams of hippuric acid in the urine.
2. Two patients with untreated pernicious anemia (see Figure 2 ) The first glycine tolerance tests were made on both patients (Cases 3 and 4) when the hemoglobin levels (31 per cent and 44 per cent) and red blood cell levels (980,000 and 1,640,000) were low. The second tests were made 6 months later when the hemoglobin levels (76 per cent and 107 per cent) and red blood cell counts (3,700,000 and 4,980,000) were nearer normal.
Before therapy. Both plasma amino nitrogen curves were flattened and below normal. The plasma urea nitrogen curve of the first patient was also low (Case 3), and was associated with a total excretion of 2714 mgm. of urea and an elevated urea clearance (180 per cent). The plasma urea nitrogen values were high in the second patient (Case 4), due presumably to retention. Only 1750 mgm. of urea were formed and the renal function was but 28 per cent of normal. The results of the liver function tests were not strikingly abnormal: 3.9 per cent retention of bilirubin and 2.5 grams of hippuric acid excreted. The slightly decreased excretion of hippuric acid probably could be attributed to the reduced renal function, since 10 days later the patient suffered from a mild transitory renal disorder of which an early phase was undoubtedly present when the test was made (see case history).
After therapy. The results of the glycine tolerance tests were essentially normal in both patients. Case 3 formed 3921 mgm. of urea and the urea clearance was 100 per cent. Case 4 excreted 2835 mgm. of urea and the urea clearance was 105 per cent, a marked improvement over that present during the first test.
3. Three patients with pernicious anemia previously treated (see Figure 3 ) This group was composed of patients in relapse '(Cases 5, 6, and 7) who had been inadequately treated with liver extract before their hospitalization. The first glycine tolerance tests were made when the hemoglobin values (43 per cent, 63 per cent, and 69 per cent) and red blood cell levels (2,060,000, 2,880,000, and 2,470,000) were low. The tests were repeated after adequate liver extract therapy when the hemoglobin percentages were 90, 87, and 84, and the red blood cell counts were 4,320,000, 4,170,000 and 3,540,000, respectively.
Before therapy. The plasma amino nitrogen curves were normal in 1 patient (Case 7) and elevated in 2 (Cases 5 and 6). In 2 (Cases 6 and 7) the plasma urea nitrogen curves were somewhat low and the peaks were delayed, indicating a retarded urea formation. The total quantity of urea formed was 1911 mgm. in the patient (Case 6) with the greater retardation, and was 2774 mgm. in the other (Case 7). The third patient (Case 5) had a normal plasma urea nitrogen curve. The output of urea was not measured and the results of the renal and liver function tests were within the normal range. the symptomatic improvement which follows the administration of liver extract the abnormality is no longer detectable. Furthermore, the low rates of formation and excretion of urea became normal after induced remission. The low curves for plasma amino and urea nitrogen observed before treatment can probably be attributed to poor absorption and not to simple loss of glycine from the bowel since the patients did not have diarrhea during the tests. Once absorbed, carbohydrates, fats and proteins have not been shown to be abnormally metabolized in sprue; indeed, the results of glucose tolerance tests are normal even at the height of symptoms if the glucose is administered intravenously. It is possible, however, that the slow rates of urea formation before therapy by the patients here reported can be accounted for partially by some hepatic dysfunction in the metabolism of amino acids. In accord with this possibility is the fact that the results of 3 liver function tests were abnormal in both patients before treatment but became normal after the remissions were established.
In the 2 patients with pernicious anemia who had not been treated with liver extract previous to admission, the plasma amino nitrogen curves were also below normal and flattened. As in the cases with sprue, these results cannot be attributed to poor absorption because of diarrhea, for both patients had normal bowel function. Either there was poor absorption in both groups because of some specific dysfunction of the gastro-intestinal tract or the glycine was quickly deaminized. The latter assumption is unlikely since, if it were true, the rates of urea formation should be rapid, and this was not the case. An elevated plasma urea nitrogen was found in 1 case (Case 4), presumably due to urea retention, since only 1750 mgm. of urea were formed, and since the renal function test was but 28 per cent of normal. There was no clear evidence of hepatic dysfunction in this patient, although Fouts, Helmer, and Zerfas (14) have shown that the results of the sodium benzoate test are somewhat abnormal in patients with pernicious anemia. In the other patient (Case 3) the plasma urea nitrogen curve was below normal and 2714 mgm. of urea were formed; the urea clearance was 180 per cent and the rate of excretion of urinary urobilinogen was abnormally elevated (65.0 to 15.0 mgm. daily). In short, since no case of sprue or untreated pernicious anemia presented evidence of abnormally increased deaminization and since no glycine was lost from the bowel during the test, it is assumed that the flat curves of plasma amino nitrogen indicate that absorption of glycine was impaired.
After therapy the curves became normal and by the same criteria it is assumed that the absorption of glycine improved. The fact that the amount of urea formed also became normal in both groups of patients is in accord with this assumption.
In the 3 tests made on patients with pernicious anemia in relapse following inadequate liver extract therapy, 1 plasma amino nitrogen curve was normal, and 2 were elevated. This fact indicates that the absorption of glycine was normal, but the rate of deaminization was possibly impaired in 2 cases. The results of renal and hepatic function tests were normal, this evidence being opposed to the presence of impaired hepatic deaminization or renal excretion as a cause of the high amino acid levels. The peaks of the plasma urea nitrogen curves were delayed in 2 patients, however, and in these the amount of urea formed was slightly less than normal (2774 mgm.) in one (Case 7) and much less than normal (1911 mgm.) in the other (Case 6). The peak of the curve was more delayed in the latter patient than in the former. The plasma urea nitrogen curve was normal in the third patient (Case 5) but the amount of urea formed was not measured. From the plasma urea nitrogen levels it appears that a subnormal rate of deaminization may be present in spite of good hepatic function, as indicated by other tests. After adequate treatment, the glycine curves became normal in all 3 patients.
The results suggest that relapse of previously treated pernicious anemia is attended by distinctly less disturbance of glycine absorption and metabolism than is shown by patients in their first attacks. It is noteworthy, however, that patients of the relapse group were tested when their anemia was much less severe than was that of either of the cases in their first attack, or of the patients with sprue.
The possibility that ischemia of the gastrointestinal tract might play a role in the poor absorption of the amino acid by patients with low blood levels can be ruled out by the observation 419 Downloaded from http://www.jci.org on October 27, 2017. https://doi.org/10.1172/JCI101143 made on 3 patients with severe refractory anemia. These had hemoglobin and erythrocyte levels as low as any of the patients with pernicious anemia or sprue, and yet their plasma amino nitrogen curves were essentially normal. Furthermore, the urea nitrogen curves were elevated in spite of normal urea clearances. Hence the absorption of glycine was probably even more rapid than the amino nitrogen levels would indicate.
Although, as previously mentioned, no patient had diarrhea during the period of the test it was still necessary to rule out more conclusively that symptom as a cause of malabsorption of glycine with resultant low curves of plasma amino nitrogen. Accordingly, the group of patients with ulcerative colitis and persistent active diarrhea was studied. In no instance was a low plasma amino nitrogen curve observed; indeed the levels were somewhat elevated, a fact supposedly due to a reduced rate of deaminization. This supposition could not be proved, however, since in Cases 16 and 17 high plasma urea values were found also, a fact referable to abnormally low rates of excretion (urea clearance 55 per cent and 20 per cent of normal, respectively). For the same reason, the subnormal sodium benzoate test results do not supply valid evidence of hepatic dysfunction as a possible cause of low deaminizing power.
In the studies already discussed, some evidence of hepatic dysfunction was at hand in those patients with sprue and untreated pernicious anemia who seemed to show evidence of poor absorption. No such evidence was found in the patients with pernicious anemia in relapse, and it was accordingly necessary to test the absorptive ability of patients with advanced hepatic insufficiency from cirrhosis. These were the only control studies which indicated a definite impairment of absorptive power. One plasma amino nitrogen curve was flat and below normal and the other was low, although a rise did appear late in the curve of the test. The urea nitrogen curves also were abnormally low. This would be expected if the defect were one of absorption. Definite evidence of hepatic dysfunction was at hand in the results of other tests on these patients.
It is suggested that the abnormal results of the glycine tolerance tests 3. Evidence of malabsorption was not demonstrable in patients with intractable diarrhea, severe refractory anemia or pernicious anemia in complete or partial remission, but was present in 2 patients with cirrhosis of the liver.
